Pim J French

Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis

Naoki Kagawa, Naoya Hashimoto, Toshihiro Kumabe, 2016, The Lancet. Oncology.

The CpG island methylator phenotype: what's in a name?

Nita Ahuja, Matty P Weijenberg, Piet A van den Brandt, 2013, Cancer research.

Gene expression profiles associated with treatment response in oligodendrogliomas.

Jord H A Nagel, Mathilde C M Kouwenhoven, Peter van der Spek, 2005, Cancer research.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Winand N M Dinjens, Jean-Yves Delattre, Denis Lacombe, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

Alberto Orfao, A. Órfão, P. French, 2011, The Journal of molecular diagnostics : JMD.

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

Pieter Wesseling, Peggy N Atmodimedjo, Hendrikus J Dubbink, 2016, Neuro-oncology.

A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951

Pieter Wesseling, Johan M Kros, M. J. van den Bent, 2011, Clinical Cancer Research.